Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules

Artificial Organs

Volumn 21, Issue 4, 1997, Pages 293-299

  Garred, Peter ^a   Mollnes, Tom Eirik ^b,c  

^a Rigshospitalet   (Denmark)

^b NORDLAND HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Artificial surface; Biocompatibility; Complement; Heparin; Integrins; Leukocytes

Indexed keywords

ADHESION; BLOOD; CHEMICAL ACTIVATION; CHLORINE COMPOUNDS; COATINGS; MOLECULES; POLYSACCHARIDES; POLYVINYL CHLORIDES;

ADHESION MOLECULES; ARTIFICIAL SURFACES; COATED TUBES; COMPLEMENT; COMPLEMENT ACTIVATIONS; HEPARIN COATINGS; INTEGRINS; LEUCOCYTES; SURFACE EXPRESSION; SURFACE MOLECULES;

BIOCOMPATIBILITY;

BIOMATERIAL; CELL ADHESION MOLECULE; COMPLEMENT; HEPARIN;

ARTICLE; BIOCOMPATIBILITY; PRIORITY JOURNAL;

EID: 0030888461     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00364.x     Document Type: Article

References (34)

1. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. J Am Med Assoc 1968;203: 1135-7.
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Engl J Med 1981;304:497-503.
3. Ruutu M, Alfhtan O, Heikkinen L, Järvinen A, Konttinen M, Lethonen T, Merikallio E, Standertskjöld-Nordenstam CG. "Epidemic" of acute urethral stricture after open-heart surgery. Lancet 1982;1:218.
4. Garred P, Olsen J, Mollnes TE, Bilde T, Egede Glahn B. Biocompatibility of urinary catheters: Effect on complement activation. Br J Urol 1989;63:367-71.
5. von Sengbusch G, Baurmeister U, Vienken J. Adaptability of cellulosic membranes to different biocompatibility parameters. In: Koch KM, Streicher E, eds. Contributions to nephrology: Biological reactions within the extracorporeal blood circuit during hemodialysis. Basel: Karger, 1987:126-33.
6. Larm O, Larsson R, Olsson PA. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 1983;11:161-73.
7. Agostini A. Bodily response to extracorporeal oxygenation. In: Dawids S, ed. Polymers: Their properties and blood compatibility. Dordrechts: Kluwer, 1989:315-23.
8. Cantaluppi A. Bodily response to extracorporeal dialysis. In: Dawids S, ed. Polymers: Their properties and blood compatibility. Dordrechts: Kluwer, 1989:325-43.
9. Mollnes TE, Harboe M. Neoepitope expression during complement activation. A model for detection of antigen changes in proteins and activation cascades. Immunologist 1993;1:43-9.
10. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988;57:321-47.
11. Atkinson JP, Farries T. Separation of self from non-self in the complement system. Immunol Today 1987;8:212-5.
12. Kazatchkine MD, Haeffner Cavaillon N. Mechanisms and consequences of complement activation during hemodialysis. Adv Exp Med Biol 1989;260:19-26.
13. Gu YJ, van Oeveren W, Boonstra PW, de Haan J, Wildevuur CRH. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass. Ann Thorac Surg 1992;53:839-43.
14. Rinder CS, Mathew J, Rinder H, Bonan J, Ault K, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
15. Videm V, Mollnes TE, Garred P, Svennevig JL. Biocompatibility of extracorporeal circulation: In vitro comparison of heparin coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991;101:654-60.
16. Videm V, Nilsson L, Venge P, Svennevig JL. Reduced granulocyte activation with heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991;15: 90-5.
17. Mollnes TE, Riesenfeld J, Garred P, Nordström E, Hogåsen K, Fosse E, Gotze O, Harboe M. A new model for evaluation of biocompatibility: Combined determination of neoepitopes of activated complement in blood and on artificial surfaces demonstrates improved biocompatibility by immobilization of heparin. Artif Organs 1995;19:909-17.
18. Bertilsson L, Elwing H, Liedberg B, Larm O, Riesenfeld J, Scholander E. Infrared characterization of complex sandwich structures: Heparin immobilized on polyethylene surfaces. Mol Eng 1994;1:49-57.
19. Garred P, Mollnes TE, Lea T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988;27:329-35.
20. Garred P, Mollnes TE, Lea T, Fischer E. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepilope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol 1988;27:319-27.
21. Riesenfeld J, Olsson P, Sanchez J, Mollnes TE. Surface modification with functionally active heparin. Med Device Technol 1995 (Special issue).
22. Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994;58:472-7.
23. Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF. Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 1981;67:223-8.
24. Maillet F, Kazatchkine MD, Glotz D, Fischer E, Rowe M. Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b. Mol Immunol 1983;20:1401-4.
25. Arnaout MA. Structure and function of the leucocyte adherence molecules CD11/CD18. Blood 1990;75:1037-50.
26. Mollnes TE, Videm V, Gotze O, Harboe M., Oppermann M. Formation of C5a during cardiopulmonary bypass - inhibition by precoating with heparin. Ann Thorac Surg 1991;52:92-7.
27. Rinder CS, Rinder HM, Smith BR, Fitch JCK, Smith JM, Tracey JB, Matis LA, Squinto SP, Rollins SA. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 1995; 96:1564-72.
28. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994;12:85-116.
29. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J Immunol 1995;155:2175-84.
30. Harvath L, Balke JA, Christiansen NP, Russell AA, Skubitz KM. Selected antibodies to the leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. J Immunol 1991;146:946-57.
31. Detmers PA, Zhou D, Powell D, Lichenstein H, Kelley M, Pironkova P. Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in intracellular compartment of neutrophils that contain alkaline phosphatase. J Immunol 1995; 155:2085-95.
32. Jahn B, Betz M, Deppisch R, Jannsen O, Hansch GM, Ritz E. Stimulation of beta-2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes. Kidney Int 1991;40:285-90.
33. Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 1991;57:64-8.
34. Rosenkranz AR, Templ E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen products formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol 1994;98:300-5.